Martignago, C.
19  results:
Search for persons X
?
1

High Frequency Device as a Therapeutic Resource in the Trea..:

, In: IFMBE Proceedings; IX Latin American Congress on Biomedical Engineering and XXVIII Brazilian Congress on Biomedical Engineering,
Santos, A. F. ; Assis, L. ; Martignago, C. C. S.... - p. 590-599 , 2023
 
?
2

Photobiomodulation Reduces Musculoskeletal Marker Related t..:

, In: XXVII Brazilian Congress on Biomedical Engineering; IFMBE Proceedings,
Gonçalves, S. R. ; Tim, C. R. ; Martignago, C.... - p. 319-323 , 2022
 
?
3

Corrigendum to "Preemptive treatment with photobiomodulatio..:

Martignago, C.C.S. ; Tim, C.R. ; Assis, L....
Journal of Photochemistry and Photobiology B: Biology.  204 (2020)  - p. 111817 , 2020
 
?
4

Preemptive treatment with photobiomodulation therapy in ski..:

Martignago, C.C.S. ; Tim, C.R. ; Assis, L....
Journal of Photochemistry and Photobiology B: Biology.  201 (2019)  - p. 111634 , 2019
 
?
6

Recurrent KIND1 (C20orf42) gene mutation, c.676insC, in a B..:

Martignago, B.C.F. ; Lai-Cheong, J.E. ; Liu, L...
British Journal of Dermatology.  157 (2007)  6 - p. 1281-1284 , 2007
 
?
7

Periostin: The bone and beyond:

Idolazzi, L ; Ridolo, E ; Fassio, A...
European Journal of Internal Medicine.  38 (2017)  - p. 12-16 , 2017
 
?
8

Muscle histopathology in myasthenia gravis with antibodies ..:

Martignago, S. ; Fanin, M. ; Albertini, E...
Neuropathology and Applied Neurobiology.  35 (2009)  1 - p. 103-110 , 2009
 
?
9

Effects of LED Photobiomodulation Therapy on the Proliferat..:

, In: XXVII Brazilian Congress on Biomedical Engineering; IFMBE Proceedings,
 
?
11

Importance of hypersensitivity in adverse reactions to drug..:

Ventura MT ; Boni E ; CECERE, ROSITA...
info:eu-repo/semantics/altIdentifier/pmid/29618951.  , 2018
 
?
13

New treatments for myasthenia: a focus on antisense oligonu..:

Angelini C ; Martignago S ; Bisciglia M
http://www.dovepress.com/new-treatments-for-myasthenia-a-focus-on-antisense-oligonucleotides-a11920.  , 2013
 
?
14

P-1 Prognostic factors and course of myasthenia gravis:

Albertini, E ; Martignago, S ; Bisciglia, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235855.  , 2011
 
?
15

P-4 Evaluating therapy outcome in Mysthenia Gravis:

Bisciglia, M ; Albertini, M.E ; Martignago, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235869.  , 2011
 
1-15